Test Compendium

Test Compendium is your definitive resource for detailed information on a wide array of diagnostic tests. Each entry in our compendium is meticulously cataloged to aid healthcare providers in selecting and interpreting the right tests for their patients.

Yes

Displaying 26 - 50 of 352

RUNX1T1/RUNX1

FISH

RUNX1T1/RUNX1 Alternative Name AML1-ETO Methodology FISH Test Description Probes 8q21.3-q22.1/21q22.11-q22.12 Disease AML, RUNX1 familial platelet disorder with associated myeloid malignancies (RUNX1-FPDMM),


CBFB

FISH

CBFB Alternative Name CBFB inv(16) Methodology FISH Test Description Probes 16q22.1 Disease Diseases associated with CBFB include Acute Myelomonocytic Leukemia, Acute Myeloid LeukemiaCBFB belongs to the


AML FISH Panel

FISH

AML FISH Panel Methodology FISH Test Description Probes (15q24.1/17q12-q21.2 & 11q23.3 & 8q21.3-q22.1/21q22.11-q22.12 & 16q22.1) Disease AMLThe PML-RARA fusion is the result of a recurrent,


APL FISH Panel

FISH

APL FISH Panel Methodology FISH Test Description Probes 15q24.1/17q12-q21.2 Disease acute promyelocytic leukemia (APL).The PML-RARA fusion is the result of a recurrent, balanced translocation between chromosomes


ATM/TP53

FISH

ATM/TP53 Methodology FISH Test Description Probes 11q22.3/17p13.1 Disease CLL, CD5+ B-Cell LymphomaATM: The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important


CEN12

FISH

CEN12 Alternative Name Trisomy 12 Methodology FISH Test Description Probes 12p11.1-q11 Disease B-CLLUsed to detect chromosome abnormalities (12p11.1-q11) in CLL to guide for prognosis and treatment. NGS


D13S319/13q34(A)

FISH

D13S319/13q34(A) Methodology FISH Test Description Probes 13q14.2/13q34 Disease B-CLL and plasma cell neoplasms (e.g., multiple myeloma).Used to detect chromosome abnormalities (13q14.2/13q34) in CLL to


B-CLL FISH Panel

FISH

B-CLL FISH Panel Methodology FISH Test Description Probes (11q22.3/17p13.1 & 12p11.1-q11 & 13q14.2/13q34) Disease CLL, CD5+ B-Cell Lymphoma, B-CLL and plasma cell neoplasms (e.g., multiple myeloma).ATM:


MYC by FISH

FISH

MYC by FISH Alternative Name c-MYC Methodology FISH Test Description Probes 8q24.21 Disease Burkitt Lymphoma and High-Grade B-Cell Lymphoma, Multiple myeloma, B-ALLThis gene is a proto-oncogene and encodes


MYC/IGH

FISH

MYC/IGH Methodology FISH Test Description Probes 8q24.21/14q32.33 Disease Burkitt Lymphoma and High-Grade B-Cell Lymphoma, Multiple myeloma, B-ALLMYC: This gene is a proto-oncogene and encodes a nuclear


Burkitt Lymphoma FISH Panel

FISH

Burkitt Lymphoma FISH Panel Methodology FISH Test Description Probes (9q34.11-q34.13/22q11.22-q11.23 & 8q24.21 & 8q24.21/14q32.33) Disease Burkitt Lymphoma and High-Grade B-Cell Lymphoma, Multiple


CCND1/IGH

FISH

CCND1/IGH Methodology FISH Test Description Probes 11q13.3/14q32.33 Disease Mantle cell lymphoma and multiple myeloma.Detection of CCND1/IGH translocation. The t(11;14)(q13;q32) translocation results in


CD5+ B-Cell Lymphoma FISH Panel

FISH

CD5+ B-Cell Lymphoma FISH Panel Methodology FISH Test Description Probes (11q13.3/14q32.33 & 11q22.3/17p13.1 & 12p11.1-q11 & 13q14.2/13q34) Disease B-Cell LymphomaDetection of CCND1/IGH translocation.


ROS1

FISH

ROS1 Methodology FISH Test Description Probes 6q22.1 Disease NSCLC, glioblastoma multiforme, cancers of the bile duct, ovary, stomach, colon, and rectumIt is designed to detect a chromosomal rearrangement


IGH/BCL2

FISH

IGH/BCL2 Alternative Name IgH/BCL2 t(14;18) Methodology FISH Test Description Probes 14q32.33/18q21.33 Disease Folicular lymphoma, Diffuse Large B cell lymphomaBCL2:This gene encodes an integral outer


BCL6

FISH

BCL6 Alternative Name B-cell lymphoma Methodology FISH Test Description Probes 3q27.3-q28 Disease Non-Hodgkin's Lymphoma, Folicular lymphoma, Diffuse Large B-Cell LymphomaThe BCL6 gene, which functions


Follicular Lymphoma FISH Panel

FISH

Follicular Lymphoma FISH Panel Methodology FISH Test Description Probes (14q32.33/18q21.33 & 3q27.3-q28) Disease Non-Hodgkin's Lymphoma, Folicular lymphoma, Diffuse Large B cell lymphomaBCL2:This gene


High Grade B-Cell Lymphoma FISH Panel

FISH

High Grade B-Cell Lymphoma FISH Panel Methodology FISH Test Description Probes (14q32.33/18q21.33 & 3q27.3-q28 & 8q24.21) Disease Burkitt Lymphoma, High-Grade B-Cell Lymphoma, Multiple myeloma,


MET

FISH

MET Methodology FISH Test Description Probes 7p11.1-q11.1/7q31.2 Disease Non-Small-Cell Lung Cancer, MDS, AML, Marginal zone lymphoma, gastric cancer, esophageal cancer, and endometrial cancerIt is designed


Lung Cancer FISH Panel

FISH

Lung Cancer FISH Panel Alternative Name NSCLC FISH Panel Methodology FISH Test Description Probes (10q11.21 & 7p11.1-q11.1/7q31.2 & 6q22.1) Disease Non-Small-Cell Lung Cancer (NSCLC) patientspanel


Mantle Cell Lymphoma FISH Panel

FISH

Mantle Cell Lymphoma FISH Panel Methodology FISH Test Description Probes 11q13.3/14q32.33 Disease Mantle cell lymphomaDetection of CCND1/IGH translocation. The t(11;14)(q13;q32) translocation results in


CEN3

FISH

CEN3 Methodology FISH Test Description Probes 3p11.1-q11.1 Disease B-cell non Hodgkin lymphoma (NHL), marginal zone B-cell lymphomaCentromeric probe for chromosome 3. Used to detect chromosome abnormalities


MET/CEN7

FISH

MET/CEN7 Methodology FISH Test Description Probes 7p11.1-q11.1/7q31.2 Disease Non-Small-Cell Lung Cancer, MDS, AML, Marginal zone lymphoma, gastric cancer, esophageal cancer, and endometrial cancerIt is


BIRC3/MALT1

FISH

BIRC3/MALT1 Methodology FISH Test Description Probes 11q22.1-q22.2/18q21.31-q21.32 Disease B-cell non Hodgkin lymphoma (NHL), extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue, high


Marginal Zone Lymphoma FISH Panel

FISH

Marginal Zone Lymphoma FISH Panel Methodology FISH Test Description Probes (3p11.1-q11.1 & 7p11.1-q11.1/7q31.2 & 11q22.1-q22.2/18q21.31-q21.32 & 11q13.3/14q32.33) Disease B-cell non Hodgkin


Discover more.

A Model Experience

With core values rooted in service and integrity, our leadership team sets the bar high.

We consistently strive to set the model for exactly how a reference laboratory should engage with both physicians and patients.

Accredited and Certified

siParadigm is accredited by CLIA (Clinical Laboratory Improvement Amendments) and certified by CAP (College of American Pathologists).

We also hold select state licensure where required.